Department of Radiation Oncology

Robert A. Lustig

faculty photo

Robert A. Lustig, M.D.

Professor of Clinical Radiation Oncology
Department: Radiation Oncology

Contact information
Perelman Center for Advanced Medicine
Department of Radiation Oncology
3400 Civic Center Blvd
2nd floor West
Philadelphia, PA 19104
Office: 215-349-8429
Fax: 215-349-5445
Education:
BA (Biology)
Franklin and Marshall College, 1965.
MD
Jefferson Medical College, 1969.
Permanent link
 
> Perelman School of Medicine   > Faculty   > Details

Selected Publications

Rathore S,Akbari H, Rozycki M, Abdullah KG, Nasrallah MP, Binder ZA., Davuluri RV, Lustig RA,Dahmane N,Bilello M, O’Rourke D & Davatzikos D : Radiomic MRI signature reveals three distinct subtypes of glioblastoma with different clinical and molecular characteristics, offering prognostic value beyond IDH1. Scientific Reports 8(1): 5087, March 2018.

Rathore S; Akbari H; Doshi J; Shukla G; Rozycki M; Bilello M; Lustig R; Davatzikos C.: Radiomic signature of infiltration in peritumoral edema predicts subsequent recurrence in glioblastoma: implications for personalized radiotherapy planning. Journal of Medical Imaging 5(2), March 2018.

Birkhoff, S; Cantrell, M.; Moriarty, H; Lustig, R.: The Usability and Acceptability of a Patient-Centered Mobile Health Tracking App Among a Sample of Adult Radiation Oncology Patients. Advances in Nursing Science 00(00): 1-17, February 2018.

J. Vogel, S. Both, M. Kirk, C. Hann-Hsiang, R. Bagatell, Y. Li, R. Womer, N. Balamuth, A. Reilly, G. Kurtz, R. Lustig, Z. Touchner, C. Hill-Kayser: Proton Therapy for Pediatric head and neck malignancies. Pediactris Blood & Cancer October 2017.

Anamalayil SJ, Teo BK, Lin A, Lustig RA, Ahn PH: Effects of full-neck volumetric-modulated arc therapy vs split-field intensity-modulated head and neck radiation therapy on low neck targets and structures. Br J Radiol 89(1062), Jun 2016 Notes: Epub 2016 Apr 4.

Evans SM, Putt, M, Yang XY, Lustig RA, Martinez-Lage M, Williams D, Desai A, Wolf R, Brem S, Koch CJ: Initial evidence that blood-borne microvesicles are biomarkers for recurrence and survival in newly diagnosed glioblastoma patients. J Neurooncol 127(2): 391-400, April 2016 Notes: Epub 2016 Jan 8.

Sumei Wang, Maria Martinez-Lage, Yu Sakai, Sanjeev Chawla, Sungheon G. Kim, Michelle Alonso-Basanta, Robert A. Lustig, Steven Brem, Suyash Mohan, Ronald L. Wolf, Arati Desai, Harish Poptani: Differentiating Tumor Progression from Pseudo-progression in Patients with Glioblastomas using Diffusion ?Tensor Imaging and Dynamic Susceptibility. AJNR AM J Neuroradiol 37(1): 28-36, Jan 2016 Notes: Epub 2015 Oct 8.

Hill-Kayser CE, Gabriel P, Volz E, Lustig RA, Tochner Z, Hahn SM, Maity A. : Factors Associated with Event Reporting in the Pediatric Radiation Oncology Population Using and Electronic Incident Reporting System. Pract Radiat Oncol 5(5): 417-422, Sept-Oct 2015 Notes: Epub 2015 Jul 26.

Koch C, Lustig R, Xiang-Yang Y, Jenkins W, Wolf R, Martinex-Lage M, Desai A, Dewight W, and Evans, S.: Microvesicles as a Biomarker for Tumor Progression versus Treatment Effect in Radiation/Temozolomide-Treated Glioblastoma Patients. Transl Oncol 7(6): 752-8, Dec 2014.

Maquilan G, Grover S, Alonso-Basanta M, Lustig RA.: Acute toxicity profile of patients with low-grade gliomas and meningiomas receiving proton therapy. Am J Clin Oncol 37(5): 438-43, Oct 2014.

back to top
Last updated: 05/23/2018
The Trustees of the University of Pennsylvania
 
Top

© The Trustees of the University of Pennsylvania | Site best viewed in a supported browser. | Site Design: PMACS Web Team.